Allites Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.50 M
as on 10-12-2024
- Revenue 218.66%
(FY 2022)
- Profit 174.88%
(FY 2022)
- Ebitda 311.05%
(FY 2022)
- Net Worth 66.47%
(FY 2022)
- Total Assets 473.48%
(FY 2022)
About Allites Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Narayanasamy Muthukrishnan and Prasannamahalakshmi Muthukrishnan serve as directors at the Company.
- CIN/LLPIN
U74999TN2017PTC116100
- Company No.
116100
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Allites Life Sciences Private Limited offer?
Allites Life Sciences Private Limited offers a wide range of products and services, including Health Conditions, Stomach Care, Heart Care.
Who are the key members and board of directors at Allites Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayanasamy Muthukrishnan  | Managing Director | 18-Apr-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasannamahalakshmi Muthukrishnan | Director | 04-Oct-2021 | Current |
Financial Performance of Allites Life Sciences.
Allites Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 218.66% increase. The company also saw a substantial improvement in profitability, with a 174.88% increase in profit. The company's net worth Soared by an impressive increase of 66.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Allites Life Sciences?
In 2021, Allites Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Andavar Pharma Private LimitedActive 1 year 5 monthsNarayanasamy Muthukrishnan and Prasannamahalakshmi Muthukrishnan are mutual person
- Allitesplus Pharmacy Private LimitedActive 2 years 15 days
Narayanasamy Muthukrishnan and Prasannamahalakshmi Muthukrishnan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Sep 2021 | ₹2.50 M | Open |
How Many Employees Work at Allites Life Sciences?
Allites Life Sciences has a workforce of 82 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allites Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allites Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
